- Home
- CGTX vs NXDT Comparison
CGTX vs NXDT Comparison
Compare CGTX & NXDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGTX | NXDT |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.8M | 170.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CGTX | NXDT |
|---|---|---|
| Price | $1.61 | $2.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.88 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 133.6K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.66% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.99 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $5.89 |
| 52 Week High | $3.83 | $13.07 |
Technical Indicators
Market Signals| Indicator | CGTX | NXDT |
|---|---|---|
| Relative Strength Index (RSI) | 50.41 | 40.05 |
| Support Level | $1.30 | $2.55 |
| Resistance Level | $1.55 | $3.04 |
| Average True Range (ATR) | 0.14 | 0.21 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 61.51 | 27.28 |
Price Performance
Historical ComparisonAbout CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.